Discovering the Next-Generation of GPCR-targeted Therapeutics to Address Metabolic Diseases with Unmet Patient Needs
Time: 10:00 am
day: Day Two AM
Details:
- Leveraging a novel drug modality and proprietary discovery platform to unlock peptide & protein GPCRs
- Advancing a pipeline of differentiated therapeutics for cardiometabolic and immunological diseases
- Capturing the untapped potential of Class A and Class B GPCRs with novel therapeutic approaches and drug-conjugates
